{"transactions":[{"id":703557,"issuer":{"id":9039,"kind":"organization","name":"HeartBeam, Inc.","symbol":"BEAT"},"owners":[{"id":28807,"kind":"person","name":"Persen Kenneth Harry","position":1,"cik":"0001942350","reported_name":"Persen Kenneth Harry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-24T20:55:21.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":105740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash."}],"balance_after":448290,"source":{"system":"sec-edgar","filing":"0001213900-26-081458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942350/000121390026081458/ownership.xml","form_type":"4"}},{"id":1162617,"issuer":{"id":9039,"kind":"organization","name":"HeartBeam, Inc.","symbol":"BEAT"},"owners":[{"id":28807,"kind":"person","name":"Persen Kenneth Harry","position":1,"cik":"0001942350","reported_name":"Persen Kenneth Harry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-05-01T15:03:46.000Z","date":"2025-04-07","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted 20,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 07, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan."}],"balance_after":441000,"derivative":{"exercise_price":1.65,"exercise_date":"2025-04-07","expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-25-038171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942350/000121390025038171/ownership.xml","form_type":"4"}},{"id":1815166,"issuer":{"id":9039,"kind":"organization","name":"HeartBeam, Inc.","symbol":"BEAT"},"owners":[{"id":28807,"kind":"person","name":"Persen Kenneth Harry","position":1,"cik":"0001942350","reported_name":"Persen Kenneth Harry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-08-05T01:43:51.000Z","date":"2023-08-02","kind":"grant","planned":false,"acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options (\"Option\" and collectively, \"Options\") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on August 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options will vest and become exercisable with respect to 40% of the shares starting August 1, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam's synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals."}],"balance_after":421000,"derivative":{"exercise_price":2.9,"exercise_date":"2023-08-02","expiration_date":"2033-08-02","underlying":"Common Stock","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0001213900-23-063798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942350/000121390023063798/ownership.xml","form_type":"4"}},{"id":1860961,"issuer":{"id":9039,"kind":"organization","name":"HeartBeam, Inc.","symbol":"BEAT"},"owners":[{"id":28807,"kind":"person","name":"Persen Kenneth Harry","position":1,"cik":"0001942350","reported_name":"Persen Kenneth Harry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-06-09T23:59:12.000Z","date":"2023-05-14","kind":"grant","planned":false,"acquired":true,"shares":169000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as of May 14, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc.  receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals."}],"balance_after":169000,"derivative":{"expiration_date":"2033-05-13","underlying":"Common Stock","underlying_shares":169000},"source":{"system":"sec-edgar","filing":"0001779372-23-000017","document":"wk-form4_1686355142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942350/000177937223000017/wk-form4_1686355142.xml","form_type":"4"}},{"id":1940407,"issuer":{"id":9039,"kind":"organization","name":"HeartBeam, Inc.","symbol":"BEAT"},"owners":[{"id":28807,"kind":"person","name":"Persen Kenneth Harry","position":1,"cik":"0001942350","reported_name":"Persen Kenneth Harry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-03-24T00:28:49.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options (\"Options\") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on March 21, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option will vest and become exercisable with respect to 25% of the shares starting March 21, 2024 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.5,"exercise_date":"2024-03-21","expiration_date":"2033-03-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001779372-23-000008","document":"wf-form4_167961771712287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942350/000177937223000008/wf-form4_167961771712287.xml","form_type":"4"}},{"id":2140629,"issuer":{"id":9039,"kind":"organization","name":"HeartBeam, Inc.","symbol":"BEAT"},"owners":[{"id":28807,"kind":"person","name":"Persen Kenneth Harry","position":1,"cik":"0001942350","reported_name":"Persen Kenneth Harry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-10-07T21:27:40.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options (\"Options\") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on September 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option will vest and become exercisable with respect to 25% of the shares starting August 2, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control."}],"balance_after":80000,"derivative":{"exercise_price":1.91,"exercise_date":"2023-08-02","expiration_date":"2032-09-16","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001779372-22-000043","document":"wf-form4_166517804228881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942350/000177937222000043/wf-form4_166517804228881.xml","form_type":"4"}}]}